Table 3. Summary of Recommendations for Preventing
Ventilator-Associated Pneumonia (VAP) in
Pediatric Patients
Recommendation Rationale
Best practices Some data that the intervention lowers VAP rates and minimal
risks of harm; potential benefits likely outweigh potential risks
Special approaches Unknown impact on VAP rates, but risk of harm likely minimal;
reasonable to consider implementing if rates remain elevated
despite basic practices
Generally NOT
recommended
Unknown impact on VAP rates and inadequate data on risks
No impact on VAP rates
a
Lowers VAP rates in adults, but no impact on duration of
mechanical ventilation, length of stay, or mortality
No recommendation Limited data on pediatric patients; no impact on VAP rates or
outcomes in adults; unclear impact on costs
a
May, however, be indicated for reasons other than VAP prevention.
Ventilator-Associated Pneumonia
